Evidence map›Paper›PMID 39905067›Full record

ArticleScientific reports2025

Magnetic susceptibility components reveal different aspects of neurodegeneration in alpha-synucleinopathies.

Oliver C Kiersnowski, Pietro Mattioli, Lucia Argenti, Laura Avanzino, Francesco Calizzano, Andrea Diociasi, Laura Falcitano, Chunlei Liu, Mattia Losa, Federico Massa and 8 more

Erratum issuedAbstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. One-Year Substantia NigraMovement disorders : official journal of the Movement Disorder Society · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Oliver C KiersnowskiIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Pietro MattioliIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Lucia ArgentiDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy.
Laura AvanzinoIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Francesco CalizzanoDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy.
Andrea DiociasiIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Laura FalcitanoIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Chunlei LiuUniversity of California Berkeley, Berkeley, United States of America.
Mattia LosaDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy.
Federico MassaIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Silvia MorbelliDepartment of Nuclear Medicine, University of Turin, Turin, Italy.
Beatrice OrsoDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genova, Genova, Italy.
Elisa PelosinIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Stefano RaffaIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Matteo PardiniIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Dario ArnaldiIRCCS Ospedale Policlinico San Martino, Genova, Italy.
Luca RoccatagliataIRCCS Ospedale Policlinico San Martino, Genova, Italy. lroccatagliata@neurologia.unige.it.
Mauro CostagliIRCCS Ospedale Policlinico San Martino, Genova, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nigrostriatal dopaminergic degeneration in alpha-synucleinopathies is indirectly reflected by low dopamine transporter (DaT) uptake through [123I]FP-CIT-SPECT. Bulk magnetic susceptibility (χ) in the substantia nigra, from MRI-based quantitative susceptibility mapping (QSM), is a potential biomarker of nigrostriatal degeneration, however, QSM cannot disentangle paramagnetic (e.g. iron) and diamagnetic (e.g. myelin) sources. Using the susceptibility source-separation technique DECOMPOSE, paramagnetic component susceptibility (PCS) and diamagnetic component susceptibility (DCS) were studied in prodromal and overt alpha-synucleinopathies, and their relationships with DaT-SPECT specific binding ratio (SBR) and clinical scores. 78 participants were included (23 controls, 30 prodromal and 25 overt alpha-synucleinopathies). Prodromal patients were subdivided into groups with positive or negative DaT-SPECT (SBR Z-scores below or above -1, respectively). Correlations of putamen and caudate SBR Z-scores with PCS and DCS in the substantia nigra, putamen, and caudate were investigated. Increased PCS was observed in the substantia nigra of prodromal alpha-synucleinopathy patients with positive DaT-SPECT compared to controls and prodromal patients with negative DaT-SPECT. SBR Z-scores in the putamen correlated with increased PCS in the substantia nigra and reduced |DCS| in the putamen, which may reflect dopaminergic degeneration ascribable to iron accumulation and nigrostriatal neuron axonal loss, respectively.

Indexed as

SynucleinopathiesAdultAgedalpha-SynucleinDopamine Plasma Membrane Transport ProteinsFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedSubstantia NigraTomography, Emission-Computed, Single-PhotonTropanesalpha-SynucleinDopamine Plasma Membrane Transport ProteinsTropanesAlpha-synucleinopathiesDECOMPOSEParkinson’s diseaseProdromal alpha-synucleinopathiesQuantitative susceptibility mappingSusceptibility source separation

Identifiers

PMID39905067
PMCPMC11794440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.